Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

concurrent chemoradiotherapy

  • You have access
    Treatment Outcomes and Prognostic Factors of Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and Fluorouracil in Advanced Head and Neck Cancer
    TAKAHIRO KUSAKA, KIYOTO SHIGA, KATSUNORI KATAGIRI, DAISUKE SAITO, SHIN-ICHI OIKAWA, AYA IKEDA, KODAI TSUCHIDA, JUN MIYAGUCHI, YU OHASHI, HISANORI ARIGA and KOZO TANNO
    Anticancer Research December 2022, 42 (12) 6047-6056; DOI: https://doi.org/10.21873/anticanres.16116
  • You have access
    Overall Survival of Small-cell Lung Cancer Patients With Malignant Central Airway Obstruction Who Received Chemotherapy Without Undergoing Transbronchial Interventions: A Single-institution Retrospective Study
    KOSUKE KASHIWABARA, SHINJI FUJII, SHINSUKE TSUMURA and KAZUHIKO SAKAMOTO
    Anticancer Research December 2022, 42 (12) 6113-6119; DOI: https://doi.org/10.21873/anticanres.16124
  • You have access
    Sarcopenia Is an Independent Prognostic Factor for Squamous Cell Carcinoma of the Cervix Treated With Concurrent Chemoradiotherapy
    SHINYU KISE, YOSHIHISA ARAKAKI, WATARU KUDAKA, TAKURO ARIGA, NAGISA KINJO, HIROSHI KOHATU and YOICHI AOKI
    Anticancer Research October 2022, 42 (10) 4887-4893; DOI: https://doi.org/10.21873/anticanres.15994
  • You have access
    Differences in the Therapeutic Effect of Chemotherapy Regimens for Concurrent Chemoradiotherapy of Locally Advanced Non-small Cell Lung Cancer
    MINORU HORIUCHI, TETSUYA OGURI, YUSUKE KAGAWA, KAZUKI SONE, SATOSHI FUKUDA, TAKEHIRO UEMURA, OSAMU TAKAKUWA, KEN MAENO, KENNSUKE FUKUMITSU, YOSHIHIRO KANEMITSU, TOMOKO TAJIRI, HIROTSUGU OHKUBO, MASAYA TAKEMURA, YUTAKA ITO and AKIO NIIMI
    Anticancer Research February 2022, 42 (2) 1073-1079; DOI: https://doi.org/10.21873/anticanres.15569
  • You have access
    Prognostic Value of Hematological Parameters in Locally Advanced Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy
    HYUN JUNG LEE, JONG MI KIM, YOO JEONG CHIN, GUN OH CHONG, SHIN-HYUNG PARK, YOON HEE LEE, DAE GY HONG and YOON SOON LEE
    Anticancer Research January 2020, 40 (1) 451-458; DOI: https://doi.org/10.21873/anticanres.13973
  • You have access
    Lymph Node Metastases Diagnosed by 18F-FDG-PET/CT in Esophageal Squamous Cell Cancer Treated With Concurrent Chemoradiotherapy
    ICHIRO OGINO, SHIGENOBU WATANABE, TOSHIHIRO MISUMI, MASAHARU HATA and CHIKARA KUNISAKI
    Anticancer Research September 2019, 39 (9) 4977-4985; DOI: https://doi.org/10.21873/anticanres.13687
  • You have access
    Sarcopenia Is Not a Prognostic Factor of Outcome in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy or Radiotherapy
    HIROFUMI MATSUOKA, KEIICHIRO NAKAMURA, YUKO MATSUBARA, NAOYUKI IDA, TAKESHI NISHIDA, CHIKAKO OGAWA, KUNIAKI KATSI, SUSUMU KANAZAWA and HISASHI MASUYAMA
    Anticancer Research February 2019, 39 (2) 933-939; DOI: https://doi.org/10.21873/anticanres.13196
  • You have access
    Outcomes of Localized Esophageal Squamous Cell Carcinoma Patients Treated With Definitive Concurrent Chemoradiotherapy Using Either Standard or High Radiotherapy Dose: A Retrospective Study Controlling for Organ at Risk Dose
    CHIA-CHIN LI, HSIN-YUAN FANG, CHEN-YUAN LIN, WEI-CHIH SHEN and CHUN-RU CHIEN
    Anticancer Research January 2019, 39 (1) 511-517; DOI: https://doi.org/10.21873/anticanres.13142
  • You have access
    Clinical Outcomes of Hypopharyngeal Cancer Receiving Definitive Radiotherapy with Concurrent Chemotherapy
    MASAKUNI SAKAGUCHI, TOSHIYA MAEBAYASHI, TAKUYA AIZAWA, NAOYA ISHIBASHI and TSUTOMU SAITO
    Anticancer Research February 2017, 37 (2) 941-947;
  • You have access
    Clinical Results for Bladder Cancer Treated by Radiotherapy Without Concurrent Standard Chemotherapy
    MASAKUNI SAKAGUCHI, TOSHIYA MAEBAYASHI, TAKUYA AIZAWA, NAOYA ISHIBASHI and TSUTOMU SAITO
    Anticancer Research October 2016, 36 (10) 5519-5525;

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire